Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 0.5308
-0.226 %
$ 1.18 M
Market Cap
-0.02
P/E
CASH FLOW STATEMENT
-6.68 M
OPERATING CASH FLOW
5.99 M
INVESTING CASH FLOW
4.62 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
PainReform Ltd.
| Net Income | -9.34 M |
| Depreciation & Amortization | 15 K |
| Capital Expenditures | -9 K |
| Stock-Based Compensation | 804 K |
| Change in Working Capital | 1.63 M |
| Others | 1.83 M |
| Free Cash Flow | -6.69 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||
| Net Income | (9.3) | (8.8) | (7.2) | (4.1) | (1.3) | (0.8) | (1.1) |
| Depreciation & Amortization | 15 K | 15 K | 7 K | 1.0 | 1 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | (1.0) | 2 K | 0 | 0 |
| Stock Based Compensation | 0.8 | 1.4 | 0.8 | 38 K | 89 K | 0 | 18 K |
| Other Operating Activities | 0.2 | 0.3 | 0.4 | 2.3 | 0.6 | 0.3 | 0.3 |
| Change in Working Capital | 1.6 | 0.7 | (0.5) | (0.9) | 35 K | (0.1) | 23 K |
| Cash From Operations | (6.7) | (6.5) | (6.6) | (2.6) | (0.6) | (0.6) | (0.9) |
| INVESTING CASH FLOW | |||||||
| Capital Expenditures | 9 K | 6 K | 50 K | 10 K | 0 | 0 | 0 |
| Other Items | 6.0 | (6.0) | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 6.0 | (6.0) | 50 K | 10 K | 0 | 0 | 0 |
| FINANCING CASH FLOW | |||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0.2 | 0.5 | 0.7 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.9 | 0 | 1.5 | 0 | 1.3 | 0 | 0 |
| Cash From Financing Activities | 4.6 | 0 | 7.5 | 17.3 | 1.5 | 0.5 | 0.7 |
| CHANGE IN CASH | |||||||
| Net Change In Cash | 3.9 | (12.5) | 0.9 | 14.7 | 0.9 | (0.1) | (0.2) |
| FREE CASH FLOW | |||||||
| Free Cash Flow | (6.7) | (6.5) | (6.6) | (2.6) | (0.6) | (0.6) | (0.9) |